Trial Details
Not RecruitingBasic Information
| Clinical ID | c2484 |
|---|---|
| Identifier | NL-OMON52357 |
| Trial Title | A Combined Phase 2/3 12-week, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy of AMT-101 in Subjects with Chronic Antibiotic-resistant Pouchitis_ - AMT-101-201 |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | inflammatory bowel disease Pouchitis;10017969 |
| Interventions | AMT-101: Once daily by mouth in the morning approximately 30 minutes before breakfast for 12 weeks. Matching placebo: Once daily by mouth in the morning approximately 30 minutes before breakfast for 12 weeks. The first dose of study treatment will be administered in clinic under the supervision of study personnel and all other doses will be self-administered at home, with details recorded in the subject diary. |
Participant Information
| Sponsor | Applied Molecular Transport Inc. |
|---|---|
| City | - |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |